Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LSP1 pseudogene 3 (LSP1P3) is a non-protein-coding pseudogene related to the LSP1 gene, cataloged under NCBI Gene ID 729862[1][6]. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional due to mutations or lack of regulatory elements that prevent them from being transcribed or translated into active protein. Although some pseudogenes can exert regulatory roles at the RNA level—such as acting as competing endogenous RNAs (ceRNAs), microRNA decoys, or sources of long noncoding RNAs—there is, as of now, no evidence that LSP1P3 serves such a function. LSP1P3 is not considered a therapeutic target, as it does not encode a functional protein and lacks known direct involvement in disease or therapeutic mechanisms[1][2][6]. Notes on correctness: - LSP1P3 is not a protein-coding gene and is generally not considered a bona fide molecular target (not a receptor, enzyme, transporter, etc.) in pharmacology or drug development[1][6]. - Its inclusion as a target would be incorrect in the context of receptor or drug target lists. It is more appropriate to refer to the parental gene, LSP1 (Lymphocyte-specific protein 1), for protein function and disease association details[3][5]. Pseudogenes like LSP1P3 may gain relevance if future research discovers a noncoding function relevant to disease or therapy—but no such evidence exists currently[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LSP1 pseudogene 3 (LSP1P3).